FDA.reportPublic FDA data

fluocinolone acetonide 0.59 MG Drug Implant

RxCUI
1191323
RxNorm name
fluocinolone acetonide 0.59 MG Drug Implant
Display name
fluocinolone acetonide 0.59 MG Drug Implant
Full name
fluocinolone acetonide 0.59 MG Drug Implant
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RetisertFLUOCINOLONE ACETONIDEBausch & Lomb Incorporated1ab0f849-2a0d-47ce-ad05-768094da8cc92026-03-31Warnings, Adverse reactionsExact identifier
rxcui: 1191323

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1ab0f849-2a0d-47ce-ad05-768094da8cc9fluocinolone acetonide 0.59 MG Intravitreal Drug Implant [PSN] · fluocinolone acetonide 0.59 MG Drug Implant [SCD]216These highlights do not include all the information needed to use RETISERT safely and effectively. See full prescribing information for RETISERT. RETISERT (fluocinolone acetonide intravitreal implant) 0.59 mg, for intravitreal use Initial U.S. Approval: 196320260331